English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    V. S. Pikalyuk, S. O. Mostovoy, M. V. Peshkov, G. F. Tkach, T. Ya. Shevchuk, L. S. Aponchuk, O. V. Usova

    MORPHOGENESIS OF THE ZERO-STAGE OSTEONECROSIS FORMATION OF THE LOWER JAW BASED ON THE USE OF AMINOBISPHOSPHONATES


    About the author: V. S. Pikalyuk, S. O. Mostovoy, M. V. Peshkov, G. F. Tkach, T. Ya. Shevchuk, L. S. Aponchuk, O. V. Usova
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation The dynamics of morphostructural changes in the mandibular bones of laboratory white rats after a 3-month exposure to pamidronic acid at the dose of 63 mg/kg was studied. Light microscopy methods were used, including qualitative and quantitative characteristics in assessing the structural state of the bone through the parameters that characterize the histoarchitectonics of the lower jaw using indices and their abbreviations proposed by the committee on histomorphometric nomenclature of American Society for Bone and Mineral Research. Three new functional indices for assessing physiological processes in bones were studied. It was established that administration of pamidronic acid to laboratory white rats for 3 months leads to myelofibrosis and focal osteosclerosis with osteodystrophic changes, similar to the processes that develop in ossifying osteitis.
    Tags aminobisphosphonate,osteonecrosis,osteocytic osteolysis,lower jaw
    Bibliography
    • Avrunin AS. Osteotsitarnoye remodelirovaniye: istoriya voprosa, sovremennyye predstavleniya i vozmozhnosti klinicheskoy otsenki. Travmatologiya i ortopediya Rossii.2012; 63, 1: 128–134. https://doi.org/10.21823/2311-2905-2012-0-1-149-156 [in Russian]
    • Volkov AV, Bolshakova GB. Gistomorfometriya kostnoy tkani v regenerativnoy meditsine. Klinicheskaya i eksperimentalnaya morfologiya. 2013; 3: 65–72. http://www.morfolhum.ru/journal/2013-no-3/ [in Russian]
    • Kutya S.A. «Zvezdchatyy obyem» – effektivnyy gistomorfo-metricheskiy pokazatel stepeni soyedinennosti elementov trabekulyarnoy seti. Tavricheskiy mediko-biologicheskiy vestnik. 2012;15(4):212–214. http://dspace.nbuv.gov.ua/handle/ 123456789/60851 [in Russian]
    • Peshkov M.V. Decalcification in histological laboratory technique. Archive of pathology. 2012; 6: 44–46. tps://www.mediasphera.ru/issues/arkhivpatologii /2020/6/downloads/ru/ 100041955201 206 1043 [in Russian]
    • Chastota vstrechayemosti bisfosfonatnogo osteonekroza (analiz arkhivnykh dannykh). Melnikova S.YU. i dr. Mezhdunarodnyy studencheskiy nauchnyy vestnik. 2016; 4–1: 120–121. URL: https://eduherald.ru/ru/article/view?id=15841 [in Russian]
    • Demkovych A, Bondarenko Y, Hasiuk P. Cytokinogenesis disorders in mechanisms of the experimental perodontitis development and their correction by flavonol Wiadomości Lekarskie. 2022. 75, 1: 47–51. doi.org/10.36740/WLek202201108
    • Bell C. and Soukup J. Histologic, Clinical, and Radiologic Findings of Alveolar Bone Expansion and Osteomyelitis of the Jaws in Cats Veterinary Pathology 2015, Vol. 52(5) 910–918 https://doi.org/10.1177/0300985815591
    • Cakarer S, Selvi F, Keskin C. Bisphosphonates and bone. In: Orthopedic Surgery. Z. Al-Aubaidi (ed.). Tech.2012;141–7. https://doi.org/ 10.5772/26333
    • Dempster DW, Compston JE, Drezner MK, Glorieux FH. Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee. J. of Bone and Mineral Research. 2013; 28(1):1–16. https://doi.org/ 10.1002/jbmr.1805
    • Directive 2010/63 was amended in 2019 by Regulation (EU) 2019/1010 to incorporate ambitious goals for reporting and transparency to help progress towards the ultimate goal of total replacement of animal use: Member States shall collect and make publicly available, on an annual basis, statistical information on the use of animals in procedures, including information on the actual severity of the procedures and on the origin and species of non-human primates used in procedures. 2019; https://translated.turbopages.org/proxy_u/en-ru.ru.85d3297c-6362f8a2-1001fe06-4722d776562/https/norecopa.no/legislation/statistics
    • McClung M, Harris S. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med. 2013 Jan;126(1):13–20. doi: 10.1016/j.amjmed.2012.
    • Mostovoy SO, Shulgin VF, Maksimova EM, Nauhatsky IA. Mineralizing process and morphological structure of the femoral bone in rats under influence of aminophosphonates. J. Exp. Integr. Med. 2014; 4(2):81–4. https://doi.org/10.5455/jeim.260214.br.019.
    • Salvatore L. Ruggiero, MD, Thomas B. Dodson. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update American Association of Oral and Maxillofacial Surgeons. J Oral Maxillofac Surg. 2014;72:1938–1956, t http://doi.org/10.1016/j.joms.2014.04.031.
    • Sven O, Christoph P. Further development of the MRONJ minipig large animal model J Craniomaxillofac Surg 2017 Sep; 45(9):1503–1514. https://doi.org/ 10.1016/j.jcms.
    • Tamaoka J, Takaoka K. Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice. Exp Ther Med. 2019 Feb;17(2):1440–1448. https://doi.org/ 10.3892/etm.2018.7076.
    Publication of the article «World of Medicine and Biology» №4(82), 2022 year, 235-240 pages, index UDK 616.716.4:615.015
    DOI 10.26724/2079-8334-2022-4-82-235-240